These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
439 related articles for article (PubMed ID: 25344976)
1. [Progress in the diagnosis and treatment of cardiac amyloidosis]. Jurczyszyn A; Engel A; Rajzer M; Czepiel J; Mazurs G Przegl Lek; 2014; 71(6):340-5. PubMed ID: 25344976 [TBL] [Abstract][Full Text] [Related]
2. Recent advances in the diagnosis and management of cardiac amyloidosis. Sher T; Gertz MA Future Cardiol; 2014 Jan; 10(1):131-46. PubMed ID: 24344669 [TBL] [Abstract][Full Text] [Related]
3. Cardiac amyloidosis: a practical approach to diagnosis and management. Kapoor P; Thenappan T; Singh E; Kumar S; Greipp PR Am J Med; 2011 Nov; 124(11):1006-15. PubMed ID: 22017778 [TBL] [Abstract][Full Text] [Related]
7. [Fibril-forming proteins: the amyloidosis. New hopes for a disease that cardiologists must know]. Arbustini E; Gavazzi A; Merlini G Ital Heart J Suppl; 2002 Jun; 3(6):590-7. PubMed ID: 12116807 [TBL] [Abstract][Full Text] [Related]
8. Cardiac Amyloidosis: Overlooked, Underappreciated, and Treatable. Rubin J; Maurer MS Annu Rev Med; 2020 Jan; 71():203-219. PubMed ID: 31986086 [TBL] [Abstract][Full Text] [Related]
9. Cardiac amyloidosis: an approach to diagnosis and management. Halwani O; Delgado DH Expert Rev Cardiovasc Ther; 2010 Jul; 8(7):1007-13. PubMed ID: 20602561 [TBL] [Abstract][Full Text] [Related]
10. Amyloid cardiomyopathy. Karafiatova L; Pika T Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub; 2017 Jun; 161(2):117-127. PubMed ID: 28145535 [TBL] [Abstract][Full Text] [Related]
11. Amyloid diseases of the heart: current and future therapies. Dubrey SW; Comenzo RL QJM; 2012 Jul; 105(7):617-31. PubMed ID: 22223674 [TBL] [Abstract][Full Text] [Related]
12. A review of transthyretin cardiac amyloidosis. Jhawar N; Moreno JCL; Chirila R Rom J Intern Med; 2023 Mar; 61(1):28-34. PubMed ID: 36278951 [TBL] [Abstract][Full Text] [Related]
13. Management of Cardiac Amyloidosis: Do's and Don'ts. Alexander KM; Witteles RM Can J Cardiol; 2020 Mar; 36(3):444-446. PubMed ID: 32033795 [TBL] [Abstract][Full Text] [Related]
14. Pathophysiology and treatment of cardiac amyloidosis. Gertz MA; Dispenzieri A; Sher T Nat Rev Cardiol; 2015 Feb; 12(2):91-102. PubMed ID: 25311231 [TBL] [Abstract][Full Text] [Related]
15. [What should we know about cardiac amyloidosis? From clinical signs to treatment]. Földeák D; Nemes A; Kalapos A; Domsik P; Kormányos Á; Krenács L; Bagdi E; Borbényi Z Orv Hetil; 2017 Nov; 158(46):1811-1818. PubMed ID: 29135289 [TBL] [Abstract][Full Text] [Related]
16. Cardiac involvement with amyloidosis: mechanisms of disease, diagnosis and management. Marcu CB; Niessen HW; Beek AM; Brouwer WP; Robbers LF; Van Rossum AC Conn Med; 2011; 75(10):581-90. PubMed ID: 22216672 [TBL] [Abstract][Full Text] [Related]
17. Pathophysiology and Therapeutic Approaches to Cardiac Amyloidosis. Griffin JM; Rosenblum H; Maurer MS Circ Res; 2021 May; 128(10):1554-1575. PubMed ID: 33983835 [TBL] [Abstract][Full Text] [Related]
18. New and Evolving Concepts Regarding the Prognosis and Treatment of Cardiac Amyloidosis. Perlini S; Mussinelli R; Salinaro F Curr Heart Fail Rep; 2016 Dec; 13(6):267-272. PubMed ID: 27900617 [TBL] [Abstract][Full Text] [Related]